Be part of the knowledge.

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Innovations in Oncology: Genitourinary Cancers

How could emerging adjuvant and neoadjuvant immunotherapy strategies transform the treatment paradigm for genitourinary (GU) cancers?

This educational series examines the current and emerging roles of immunotherapy and antibody-drug conjugates in non-muscle-invasive and muscle-invasive bladder cancer. The series also dives into strategies for selecting and sequencing immunotherapies for patients with advanced renal cell carcinoma.

Provided by:

In Partnership with:

Episodes 1-1 of 1

Schedule16 Apr 2024